Cargando…

Prevalence and nature of manufacturer-sponsored patient support programs for prescription drugs in Canada: a cross-sectional study

BACKGROUND: Globally, pharmaceutical companies offer patient support programs in tandem with their products, which aim to enhance medication adherence and patient experience through education, training, support and financial assistance. We sought to identify the proportion and characteristics of suc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Grundy, Quinn, Quanbury, Ashton, Hart, Dana, Chaudhry, Shanzeh, Tavangar, Farideh, Lexchin, Joel, Gagnon, Marc-André, Tadrous, Mina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	CMA Impact Inc. 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681678/ https://www.ncbi.nlm.nih.gov/pubmed/38011930 http://dx.doi.org/10.1503/cmaj.230841

Ejemplares similares

CETA and pharmaceuticals: impact of the trade agreement between Europe and Canada on the costs of prescription drugs
por: Lexchin, Joel, et al.
Publicado: (2014)

A Better Prescription: Advice for a National Strategy on Pharmaceutical Policy in Canada
por: Morgan, Steven G., et al.
Publicado: (2016)

A comparison of educational events for physicians and nurses in Australia sponsored by opioid manufacturers
por: Grundy, Quinn, et al.
Publicado: (2021)

Development Time and Patent Extension for Prescription Drugs in Canada: A Cohort Study
por: Lexchin, Joel
Publicado: (2020)

Impact of the COVID-19 Controlled Drugs and Substances Act exemption on pharmacist prescribing of opioids, benzodiazepines and stimulants in Ontario: A cross-sectional time-series analysis
por: Chang, Ann, et al.
Publicado: (2022)

The Costs of Industry-Sponsored Drug Trials in Canada
por: Tran, Dat T., et al.
Publicado: (2019)

Quality of advertisements for prescription drugs in family practice medical journals published in Australia, Canada and the USA with different regulatory controls: a cross-sectional study
por: Diep, Dion, et al.
Publicado: (2020)

Canada and the pharmaceutical industry in the time of COVID-19
por: Lexchin, Joel
Publicado: (2023)

Marketing before patenting: implications for price controls in Canada
por: Lexchin, Joel
Publicado: (2010)

Health Canada's Proposal to Accelerate New Drug Reviews
por: Lexchin, Joel
Publicado: (2020)

Time to Marketing of Generic Drugs After Patent Expiration in Canada
por: Lexchin, Joel
Publicado: (2021)

Canada and access to medicines in developing countries: intellectual property rights first
por: Lexchin, Joel
Publicado: (2013)

It’s Time to Finally Kill the Zombies Comment on "Universal Pharmacare in Canada"
por: Lexchin, Joel
Publicado: (2020)

'Linkage' pharmaceutical evergreening in Canada and Australia
por: Faunce, Thomas A, et al.
Publicado: (2007)

Canada's Patented Medicine Notice of Compliance regulations: balancing the scales or tipping them?
por: Lexchin, Joel
Publicado: (2011)

Time to market for drugs approved in Canada between 2014 and 2018: an observational study
por: Lexchin, Joel
Publicado: (2021)

After More Than 50 Years, Pharmacare (and Dental Care) are Coming to Canada
por: Lexchin, Joel
Publicado: (2022)

The potential benefits of a national vaccine registry for Canada
por: Gorfinkel, Iris S., et al.
Publicado: (2021)

Complaints about Violations of Voluntary and Pharmaceutical Industry-Run Medicine Promotion Codes in Canada
por: Lexchin, Joel
Publicado: (2023)

How safe are new drugs? Market withdrawal of drugs approved in Canada between 1990 and 2009
por: Lexchin, Joel
Publicado: (2014)

Health Canada's use of its priority review process for new drugs: a cohort study
por: Lexchin, Joel
Publicado: (2015)

How Safe and Innovative Are First-in-Class Drugs Approved by Health Canada: A Cohort Study
por: Lexchin, Joel
Publicado: (2016)

Pharmaceutical company spending on research and development and promotion in Canada, 2013-2016: a cohort analysis
por: Lexchin, Joel
Publicado: (2018)

Increase in Drug Spending in Canada Due to Extension of Data Protection for Biologics: A Descriptive Study
por: Lexchin, Joel
Publicado: (2019)

Donations Made and Received: A Study of Disclosure Practices of Pharmaceutical Companies and Patient Groups in Canada
por: Lexchin, Joel
Publicado: (2021)

Health Canada: optimizing transparency and its impact for patients
por: Abi-Jaoude, Elia, et al.
Publicado: (2021)

Health Canada’s use of expedited review pathways and therapeutic innovation, 1995–2016: cross-sectional analysis
por: Lexchin, Joel
Publicado: (2018)

Time to potential for listing of new drugs on public and private formularies in Canada: a cross-sectional study
por: Lexchin, Joel
Publicado: (2022)

The Cost of Pushing Pills: A New Estimate of Pharmaceutical Promotion Expenditures in the United States
por: Gagnon, Marc-André, et al.
Publicado: (2008)

Does industry-sponsored education foster overdiagnosis and overtreatment of depression, osteoporosis and overactive bladder syndrome? An Australian cohort study
por: Mintzes, Barbara, et al.
Publicado: (2018)

Quality and Quantity of Information in Summary Basis of Decision Documents Issued by Health Canada
por: Habibi, Roojin, et al.
Publicado: (2014)

Postmarket safety in Canada: are significant therapeutic advances and biologics less safe than other drugs? A cohort study
por: Lexchin, Joel
Publicado: (2014)

Information about confirmatory studies required for new drugs conditionally approved by Health Canada: A cross-sectional study
por: Lexchin, Joel
Publicado: (2022)

Prediction of therapeutic value of new drugs approved by health Canada from 2011−2020: A cross-sectional study
por: Lexchin, Joel
Publicado: (2023)

New drug submissions in Canada and a comparison with the Food and Drug Administration and the European Medicines Agency: Cross-sectional analysis
por: Lexchin, Joel
Publicado: (2023)

Pharmaceutical security for Canada
por: Lee, Shoo K., et al.
Publicado: (2022)

Sponsor Acknowledgement
Publicado: (2015)

Sponsor's Foreword
por: Shurtleff, David, et al.
Publicado: (2007)

Sponsor Acknowledgement
Publicado: (2018)

Sponsor Acknowledgement
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_0rkn05vtjmv0cqis6e4pl49jig